2021-11-15T15:36:38-06:00 2020-12-31 571157523 APRIO LLP 7 PENN PLAZA NEW YORK NY 10001 990 2020-01-01 200989212 DKMS DKMS 2122096705 100 BROADWAY 6TH FLOOR NEW YORK NY 10005 AJAY SAINI VP OF FINANCE & ADMINISTRATION 2122096705 2021-11-15 1 AJAY SAINI 999009999 BRIAN STEIN CPA P00370567 2126978540 2021-11-15 3 AAL1 IAL1 2020 2022-09-23 18:48:47Z AJAY SAINI 100 BROADWAY 6TH FLOOR NEW YORK NY 10005 44214161 0 X WWW.DKMS.ORG X 2004 DC DKMS LEADS THE FIGHT TO DEFEAT BLOOD CANCER BY EMPOWERING PEOPLE TO TAKE ACTION, GIVE BONE MARROW AND SAVE LIVES. DKMS IS PART OF THE LARGEST BONE MARROW DONOR CENTER IN THE WORLD. 5 2 87 5548 0 0 6060885 4301022 44386509 38660815 719 0 -516004 1053327 49932109 44015164 0 0 0 0 7392044 6381030 0 0 1465286 42215675 36959947 49607719 43340977 324390 674187 14562407 14874997 10370086 10008489 4192321 4866508 X DKMS LEADS THE FIGHT TO DEFEAT BLOOD CANCER BY EMPOWERING PEOPLE TO TAKE ACTION, GIVE BONE MARROW AND SAVE LIVES. DKMS IS THE LARGEST BONE MARROW DONOR CENTER IN THE WORLD. DKMS' PRINICPAL ACTIVITES ARE TO: 1) RECRUIT BONE MARROW DONORS TO INCREASE THE CHANCES FOR PATIENTS TO FIND A LIFE-SAVING DONOR MATCH; 2) COORDINATE THE TRANSPORTS OF BONE MARROW OR BLOOD STEM CELL PRODUCTS FROM GERMAN DONORS TO U.S. PATIENTS; AND 3) FACILITATE BONE MARROW TRANSPLANTS BETWEEN DKMS' DONORS AND BLOOD CANCER PATIENTS WORLDWIDE. 0 0 27845507 33199540 TRANSPORT FACILITATION: COORDINATED THE TRANSPORTS OF 1,341 BONE MARROW OR BLOOD STEM CELLS PRODUCTS FROM GERMANY TO U.S PATIENTS. THIS PROVIDED THEM WITH A SECOND CHANCE AT LIFE. (IN 2019 - 1,382). 4543603 0 DONOR RECRUITMENT: RECRUITED 43,909 (86,003 IN 2019) VOLUNTEER BONE MARROW & BLOOD STEM CELL DONORS. THIS INCREASES THE CHANCES FOR PATIENTS DEALING WITH VARIOUS BLOOD CANCERS TO FIND A LIFE -SAVING DONOR MATCH. 3520515 5461275 REQUEST MANAGEMENT: FACILITATED 371 (438 IN 2019) COLLECTIONS OF BONE MARROW AND BLOOD STEM CELL PRODUCTS FROM UNRELATED VOLUNTEER DONORS, WHICH ARE TRANSPLANTED INTO PATIENTS, THUS PROVIDING A SECOND CHANCE AT LIFE FOR THOSE PATIENTS. 966089 1083174 MARKETING TO TRANSPLANT CENTERS. 966089 1083174 36875714 1 0 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 1 118 0 87 1 0 0 0 0 0 1 1 0 0 0 0 X 5 2 1 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CT DC FL GA HI IL KS KY LA ME MD MA MI MS NH NJ NM NY NC OH PA RI SC TN WA WI MN OK OR UT VA WV CO NV ND X AJAY SAINI 2122096705 100 BROADWAY 6TH FLOOR NEW YORK NY 10005 AJAY SAINI VICE PRESIDENT OF FINANCE & ADMINISTRATION 40.00 X 143565 0 16293 AGATA MARASZEK-DUDEK VP OF DONOR RECRUITMENT 40.00 X 215279 0 30699 DAVID MEANS DIRECTOR OF DONOR MANAGEME 40.00 X 155556 0 17529 514400 0 64521 3 0 1 0 DKMS GERMANY KRESSBACH 1 TUEBINGEN GM 72072 SEE SCHEDULE O 24890580 ADP TOTAL SOURCE 10201 SUNSET DRIVE MIAMI FL 33173 PAYROLL AND BENEFITS 7169534 DKMS LIFE SCIENCE LAB GMBH FIEDLERSTR 34 DRESDEN GM 01307 SEE SCHEDULE O 1120864 3 3514521 786501 4301022 TRANSPORT FACILITATION FEES 900099 33199540 33199540 REQUEST MANAGEMENT FEES 900099 5461275 5461275 38660815 130825 3514521 198997 -68172 -68172 FOREIGN EXCHANGE GAIN/(LOSS) 900099 38325 38325 1083174 1083174 1121499 44015164 39743989 0 -29847 374400 198512 120000 55888 4698432 2850756 1542679 304997 130717 78561 42836 9320 789441 474454 258700 56287 388040 233212 127160 27668 1601232 298745 920311 382176 1442554 1435340 7214 897930 707138 153238 37554 976827 87653 738633 150541 1258628 557658 572570 128400 170680 39415 131265 112826 112826 191956 191956 TRANSPORT OPERATIONS 27674435 27674435 LAB & DONOR RECRUIT FEE 2229719 2229719 OTHER EXPENSES 334079 7781 21057 305241 REPAIRS AND MAINTENANCE 34424 34424 34657 2335 32322 43340977 36875714 4999977 1465286 1799 1799 7098484 8137085 466712 12 3292131 4279332 642777 326780 1640608 1560014 193420 80594 2867084 2049395 14562407 14874997 7188891 7574189 30856 30856 3150339 2403444 10370086 10008489 X 4192321 4866508 4192321 4866508 14562407 14874997 674187 0 X 0 1 X 1 0 X 7317257 7172201 7431545 6060885 4301022 32282910 7317257 7172201 7431545 6060885 4301022 32282910 6594674 25688236 238 658 778 719 0 2393 -46168 114389 2816 287783 1121155 1479975 33765278 207182133 0.76080 0.70510 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FOREIGN EXCHANGE GAIN/LOSS - 2016 AMOUNT: $ -46,168. 2017 AMOUNT: $ -14,516. 2018 AMOUNT: $ -26,564. 2019 AMOUNT: $ -3,849. 2020 AMOUNT: $ 37,981. LEASING SUBLEASE IMPAIRMENT ADJ OTHER ACCT ADJ - 2017 AMOUNT: $ 122,835. OTHER MISC REFUND AND REIMBURSEMENTS - 2017 AMOUNT: $ 6,070. 2018 AMOUNT: $ 29,380. 2019 AMOUNT: $ 291,632. 2020 AMOUNT: $ 1,083,174. 218811 165959 52852 791092 791544 -452 630705 602511 28194 80594 RIGHT TO USE LEASE ASSETS 2048463 SECURITY DEPOSIT 932 2049395 LEASE OBLIGATIONS 2403444 2403444 X 44083336 68172 68172 44015164 0 44015164 43409149 68172 68172 43340977 0 43340977 PART X, LINE 2: MANAGEMENT EVALUATED DKMS' TAX POSITIONS AND CONCLUDED THAT, AS OF DECEMBER 31, 2020 AND 2019, THERE WERE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN. ACCORDINGLY, NO INTEREST OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS HAVE BEEN ACCRUED IN THE ACCOMPANYING FINANCIAL STATEMENTS. DKMS IS SUBJECT TO AUDITS BY TAXING JURISDICTIONS; HOWEVER, NO AUDITS FOR ANY TAX PERIODS ARE CURRENTLY IN PROGRESS. MANAGEMENT BELIEVES THAT DKMS IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS ENDED ON OR PRIOR TO DECEMBER 31, 2015. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT DIRECT EXPENSES/NET LOSS 68,172. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT DIRECT EXPENSES/NET LOSS 68,172. GALA 2020 3565605 3514521 51084 0 65836 133161 AWARDS BREAKFAST 79741 79741 3645346 3514521 130825 65836 133161 198997 -68172 X 0 0 0 0 0 0 0 0 0 AGATA MARASZEK-DUDEK VP OF DONOR RECRUITMENT 122310 0 35593 0 57376 0 4767 0 25932 0 245978 0 0 0 DAVID MEANS DIRECTOR OF DONOR MANAGEME 135000 0 20556 0 0 0 4667 0 12862 0 173085 0 0 0 AJAY SAINI VICE PRESIDENT OF FINANCE & ADMINIST 135000 0 8565 0 0 0 4307 0 11986 0 159858 0 0 0 DKMS GERMANY SOLE MEMBER OF DKMS 25335000 SEE PART V 0 PART IV, COLUMN D - BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS DR. ALEXANDER SCHMIDT IS THE SECRETARY OF THE BOARD OF DKMS AND A BOARD MEMBER OF DKMS. HE IS A MEMBER OF THE EXECUTIVE MANAGEMENT TEAM OF DKMS GERMANY SERVING AS CHIEF MEDICAL OFFICER.APPROXIMATELY $24.8 MILLION FOR SERVICES PERFORMED UNDER THE DISTRIBUTION AND IMPORT AND EXPORT AGREEMENT WITH DKMS-G;$535,000 FOR SERVICES PERFORMED UNDER THE COST SHARING AGREEMENT WITH DKMS-G FOR COMPUTER SERVICES BY DKMS-G FOR DKMS AND BILLED TO DKMS-G BY THIRD PARTY VENDORS.TOTAL: $25,335,000. FORM 990, PART VI, SECTION A, LINE 2 DKMS CONDUCTS BUSINESS TRANSACTIONS REGULATED BY SEVERAL AGREEMENTS WITH DKMS DEUTSCHE KNOCHENMARKSPENDERDATEI GEMEINNUETZIGE GESELLSCHAFT MBH, (DKMS-G) HEADQUARTERED AT KRESSBACH 1, 72072 TUEBINGEN, GERMANY. DKMS-G IS THE SOLE MEMBER OF DKMS. THE FOUNDATION DKMS STIFTUNG LEBEN SPENDEN (DKMS-SLS) IS THE MOTHER ORGANIZATION OF DKMS-G. KATHARINA HARF IS CHAIR PERSON OF THE BOARD OF DKMS. FORM 990, PART VI, SECTION A, LINE 6 DKMS WAS INCORPORATED AS A MEMBERSHIP ORGANIZATION. THE MEMBERS ELECT THE MEMBERS OF THE GOVERNING BODY (BUT NOT IF THE PERSONS ON THE GOVERNING BODY ARE THE ORGANIZATION'S ONLY MEMBERS) OR THEIR DELEGATES. FORM 990, PART VI, SECTION A, LINE 7A THE INITIAL DIRECTORS SHALL BE THOSE PERSONS WHOSE NAMES AND ADDRESSES ARE SET FORTH IN THE ARTICLES OF INCORPORATION AND THEY SHALL SERVE UNTIL THE FIRST ANNUAL MEETING OF THE MEMBER AND UNTIL THE ELECTION AND QUALIFICATION OF THEIR SUCCESSORS. THEREAFTER, DIRECTORS SHALL BE ELECTED AT THE ANNUAL MEETING OF THE MEMBER OR AT ANY ADJOURNMENT THEREOF. EACH DIRECTOR SHALL CONTINUE IN OFFICE UNTIL THE ANNUAL MEETING OF THE MEMBER HELD NEXT AFTER THE ELECTION OF SUCH DIRECTOR AND UNTIL THE ELECTION AND QUALIFICATION OF A SUCCESSOR. VACANCIES: ANY VACANCY OR VACANCIES CREATED BY THE DEATH, RESIGNATION OR INCAPACITY TO ACT OF ANY DIRECTOR BEFORE THE EXPIRATION OF SUCH DIRECTOR'S TERM, OR BY THE CREATION OF ONE OR MORE NEW DIRECTORSHIPS, MAY BE FILLED AT ANY MEETING OF THE BOARD BY A MAJORITY OF THE DIRECTORS THEN IN OFFICE. A DIRECTOR ELECTED TO FILL A VACANCY SHALL HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF THE MEMBER AND UNTIL THE ELECTION AND QUALIFICATION OF A SUCCESSOR. FORM 990, PART VI, SECTION A, LINE 7B BOARD MEMBER ELECTION AND REMOVAL IS SUBJECT TO APPROVAL BY THE MEMBERSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE CEO AND THE ASSISTANT TREASURER. A COMPLETED COPY OF THE FORM 990 IS PROVIDED TO ALL MEMBERS OF THE BOARD BEFORE THE FORM IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE REQUIRED TO SIGN A CONFLICT OF INTEREST STATEMENT ANNUALLY. THE EXISTING POTENTIAL CONFLICTS THAT HAVE BEEN DISCLOSED ARE BEING AVOIDED BY THE DIRECTORS BY EXCUSING THEMSELVES FROM BOARD DISCUSSIONS AND VOTES PERTAINING TO THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 DKMS AMERICAS HAS BOARD APPROVED COMMITMENT AUTHORITY AND ACTION GUIDELINES THAT STATE: "BOARD OF DIRECTORS APPROVES SALARIES OF CEO. CEO APPROVES SALARIES OF ALL OTHER EMPLOYEES." REVIEW, DISCUSSION, ADJUSTMENTS OR INCREASES OF SALARIES OF ALL EMPLOYEES ARE CONDUCTED BY MEMBERS OF MANAGEMENT AND THE CEO. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. DKMS DEUTSCHE KNOCHENMARKSPENDERDATEI KRESSBACH 1 TUEBINGEN GM 72072 BONE MARROW GM N/A N/A N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 DKMS GERMANY C 0 FMV DKMS GERMANY (DISTRIBUTION IMPORT EXPORT OF BONE MARROW AND STEM CELLS) M 26398785 FMV DKMS LIFE SCIENCE LAB (HIGH RESOLUTION TYPING) M 1120864 FMV DKMS GERMANY (THE COST SHARING AGREEMENT) N 535000 FMV